SPOTLIGHT -
Heather Woolery-Lloyd, MD, FAAD: Interview on Common Skin of Color Dermatoses
An interview on the SDPA 2022 presentation of Dr. Woolery-Lloyd in which she discusses dermatoses affecting patients of color.
Orit Markowitz, MD: Artificial Intelligence, Patient Knowledge on Skin Cancer
A discussion with Dr. Markowitz on her presentation from SDPA 2022, during which she described various gaps in knowledge on skin health and future innovations she hoped to see.
Ruxolitinib Cream Improves Atopic Dermatitis Pain, Anxiety and Depression Over 52 Weeks
New long-term phase 3 data show adults and adolescents both improved measures of quality of life when treated with either of 2 doses of ruxolitinib cream.
Orit Markowitz, MD: How to Distinguish Skin Cancer from Less Dangerous Skin Conditions
An interview with Dr. Markowitz on her presentation at SDPA 2022 presentation entitled ‘Skin of Color,’ regarding differentiating skin cancer from other conditions.
Ted Rosen, MD: Seborrheic Dermatitis, Tinea Versicolor, Other Conditions Resembling Vitiligo
An interview with Dr. Rosen regarding his SDPA 2022 presentation on dermatologic conditions with white spots that are often misdiagnosed as vitiligo.
Ted Rosen, MD: Potential Reasons for Misdiagnosis of White Spots as Vitiligo
A discussion with Dr. Rosen on one of his SPDA 2022 presentations, highlighting his reason for choosing the topic and exploring vitiligo misdiagnosis.
Dupilumab Maintains Atopic Dermatitis Clearance, Symptom Benefit Over 4 Years
Findings from the ongoing LIBERTY AD OLE trial show the sustained long-term effect of the biologic therapy for eczema.
Jennifer Orozco, DMSc, PA-C: Resources for Physician Associates and ‘PAs Go Beyond’
A discussion with Dr. Orozco on her SDPA 2022 presentation, discussing useful resources for physicians and PAs looking to get involved in the PAs Go Beyond campaign.
Rajani Katta, MD: Chronic Inflammatory Skin Disease and Obesity Comorbidities
In her SDPA 2022 presentation interview, Dr. Katta explores gaps in knowledge regarding the connection between skin disease and dietary health, as well as ways to address these concerns.
Rajani Katta, MD: Connection Between Obesity, Dietary Health, and Dermatology
Dr. Katta’s interview regarding her SDPA 2022 presentation, during which she discusses the topic of obesity, dietary health, and their relationship with skin conditions like psoriasis.
Patients with Intertriginous Area Psoriasis Frequently Report Embarrassment, Sexual Distress
Online survey results show adults with psoriasis in specific areas may be treating and monitoring disease without clinician guidance—sometimes out of embarassment.
Tildrakizumab Improves Wellbeing, Quality of Life for Psoriasis Patients
Long-term, real-world data show the IL-23 inhibitor benefits patient-reported measures of psychological wellbeing.
Dupilumab Quickly, Significantly Improves Sleep Quality in Atopic Dermatitis Patients
New data show adults receiving the biologic for eczema may see improvements in sleep disturbance within 4 weeks.
Rajani Katta, MD: Psoriasis, Other Dermatologic Conditions Connected to Obesity
An interview with Dr. Katta on her SDPA 2022 presentation, in which she covers the topic of obesity and its relationship to skin conditions such as plaque psoriasis.
SDPA 2022 Presentation Highlights: Dermatologic Conditions with Skin Depigmentation Resembling Vitiligo
In one of his SDPA 2022 presentations, Dr. Rosen spoke on different dermatological conditions with vitiligo-like presentations.
Dupilumab Rapidly, Significantly Improves Eczema Rashes, Itching in Infants, Toddlers
Phase 3 data suggest children aged <6 months to 5 years old have benefit in itch relief and skin clearance as soon as 1 week into systemic therapy regimens.
SDPA 2022 Presentation Highlights: Psoriasis Primer, Upcoming Biologic Therapies
During her SDPA 2022 presentation, Cynthia Trickett explored the topic of psoriasis, including comorbidities and treatment options.
Tralokinumab Provides Atopic Dermatitis Symptom, Severity and Quality of Life Benefit at 16 Weeks
New data from ECZTRA 1 and 2 show patients unable to achieve complete skin clearance nonetheless benefitted in at least 1 component of disease improvement.
Jennifer Orozco, DMSc, PA-C: Key Points from Presentation on ‘PAs Go Beyond’ Campaign
An interview on several major highlights from Dr. Orozsco’s presentation about the greater visibility and importance of physician associates at SDPA 2022.
Jennifer Orozco, DMSc, PA-C: Raising Awareness on Importance of Physician Associates in the Medical Workforce
An interview with Dr. Orozco regarding her presentation at SDPA 2022 on the topic of physician associates and their value in the modern medical system.
Robert Kirsner MD, PhD: Gaps in Knowledge on Wound Care in Dermatology Field
An SDPA 2022 interview with Dr. Robert Kirsner regarding his presentation regarding the topic of wound healing and related changes in the field.
Robert Kirsner MD, PhD: Presentation Highlights from ‘Healing the Unhealable Wound’
An interview at the SDPA 2022 Conference on major talking points from Dr. Robert Kirsner’s presentation on wound care with dermatologists and physician associates.
Robert Kirsner MD, PhD: Gaps in Knowledge on Wound Care in the Dermatology Field
An interview from SDPA 2022 regarding highlights from Dr. Robert Kirsner’s presentation on dermatologists and wound healing.
The Adequate Evaluation Teams, Treatment Plans for Stevens-Johnson Syndrome
Travis Vandergriff, MD, discusses the unique collaboration with ophthalmologists and urologists in the rare skin condition.
Tapinarof Cream Benefits Psoriasis Regardless of Baseline Disease Severity, Duration
An analysis of PSOARING 1 and 2 data show the topical therapy is efficacious across a wide spectrum of psoriatic disease and patient demographics.
Guselkumab Linked to Improved Psoriasis Treatment Continuation, Remission
An analysis suggests patients on the biologic fared better with adherence and outcomes than those on competitors including adalimumab.
The Signs and Symptoms of Stevens-Johnson Syndrome
A dive into the manifestation of the rare skin condition, and the impactful role of dermatologists in diagnosing it early.
Encapsulated Benzoyl Peroxide Cream, Tretinoin Combination Effectively & Safely Treats Acne
New phase 3 data show a microencapsulated form of the topical antiseptic and vitamin D derivative is beneficial and tolerable over 12 weeks.
The Pitfalls, Benefits of Influencing Dermatology Social Media
Savanna Perry, PA-C, discussed the challenge of standing out over influencers and estheticians regarding clinical dermatology insight, and the unique offerings of different platforms.
Tralokinumab Benefits Adolescent Eczema Patient-Reported Outcomes at 16 Weeks
New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.
